02 May 2003
Regulation of microglial functions by PARP-1 – a target for therapeutic interventions?
O. UllrichMed Sci Monit 2003; 9(1): 73-0 :: ID: 15216
Abstract
During the last decade of neurobiological research, it has become evident that inflammatory pathways in the CNS, involving a network of non-neuronal and neuronal cells, are important contributors to the onset and progress of several major neurodegenerative diseases [1]. One major component of inflammatory neuronal damage is the transformation of microglia cells into activated immunoeffector cells and their migration towards the sites of injury, where they produce large amounts of toxic cytokines and oxygen radicals [2]. During this transformation, PARP-1 is highly activated and enables microglia cells to cope with oxidative challenges, in particular by upregulating the proteasomal degradation of damaged nuclear proteins [3]. Besides the initiation of intracellular defense pathways, PARP-1-dependent signalling is also involved in regulating specific functions of activated microglia: It regulates the expression of the integrin CD11a through interaction with the translocated NF-kB and therefore strongly controls migration into the regions of neuronal injury [4]. Furthermore, it enhances the production of the proinflammatory cytokine TNF-alpha and of the antiinflammatory endocannabinoid 2-AG, which in turn downregulates the release of nitric oxide. We are therefore considering PARP-1 to be a multiple player in the concert of neuroinflammation, in which therapeutic interventions directed against PARP-1 would affect both neuronal and non-neuronal components. Downregulation of PARP-1 specifically in microglia almost completely abrogates microglial migration and prevents neurons from secondary damage. This renders PARP-1 a target for therapeutic strategies in neurodegenerative diseases, in which pathological microglia activation and migration play a major role. References: 1.Floyd RA et al: Free Radic Biol Med, 1999; 26: 1346-1355 2.Mabuchi T et al: Stroke, 2000; 31(7): 1735-1743 3.McGeer PL et al: Brain Res Rev, 1995; 21: 195-218 4.Ullrich O et al: FASEB J, 2001; 15: 1460-1462 5.Ullrich O et al: Nature Cell Biol, 2001; 3: 1035-1042
Keywords: neuroinflammation, Microglia, Cytokines, Integrins
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
15 Apr 2024 : Laboratory Research
The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in OsteoarthritisMed Sci Monit In Press; DOI: 10.12659/MSM.943738
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
08 Mar 2024 : Animal Research
Modification of Experimental Model of Necrotizing Enterocolitis (NEC) in Rat Pups by Single Exposure to Hyp...Med Sci Monit In Press; DOI: 10.12659/MSM.943443
18 Apr 2024 : Clinical Research
Comparative Analysis of Open and Closed Sphincterotomy for the Treatment of Chronic Anal Fissure: Safety an...Med Sci Monit In Press; DOI: 10.12659/MSM.944127
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952